Valuation: Genpharmasec Limited

Market Cap 648M 6.76M 5.86M 5.53M 5.01M 9.41M 9.47M 66.01M 25.44M 329M 25.39M 24.83M 1.04B P/E 2025
94.5x
P/E 2026 26.9x
Enterprise Value 897M 9.35M 8.11M 7.65M 6.94M 13.02M 13.11M 91.35M 35.2M 455M 35.13M 34.36M 1.45B EV / Sales 2025
2.96x
EV / Sales 2026 0.49x
Free-Float
54.91%
Yield 2025 *
-
Yield 2026 -
1 day-3.42%
1 week-1.74%
1 month+14.14%
3 months-0.88%
6 months+9.71%
Current year-13.74%
1 week 1.1
Extreme 1.1
1.22
1 month 0.9
Extreme 0.9
1.36
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.15
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
11.08
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 39 01/11/2022
Compliance Officer - 27/03/2024
Director TitleAgeSince
Director/Board Member 57 02/01/2019
Director/Board Member 58 02/01/2019
Director/Board Member - 01/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
-3.42%-1.74%-40.84%-72.84% 6.76M
+1.12%-4.84%-22.91%+0.43% 178B
+3.12%-0.39%-0.24%+14.45% 120B
+1.45%-1.43%+7.84%+84.32% 62.25B
-0.45%-4.27%+3.07%+33.55% 48.54B
+2.85%-0.99%-2.10%-30.88% 49.82B
+1.99%-3.66%+11.10%-16.61% 31.95B
+0.18%-10.93% - - 28.59B
+2.59%+4.48%+40.12%-10.73% 25B
-0.88%-3.61%-11.03%+1.86% 21.59B
Average +0.31%-3.86%-1.67%+0.39% 56.61B
Weighted average by Cap. +0.37%-3.32%-4.59%+11.89%

Financials

2025 2026
Net sales 337M 3.52M 3.05M 2.88M 2.61M 4.9M 4.93M 34.36M 13.24M 171M 13.21M 12.92M 544M 1.4B 14.6M 12.65M 11.94M 10.83M 20.32M 20.47M 143M 54.94M 710M 54.84M 53.63M 2.26B
Net income 12.31M 128K 111K 105K 95.29K 179K 180K 1.25M 483K 6.25M 482K 472K 19.86M 16.04M 167K 145K 137K 124K 233K 235K 1.63M 630K 8.14M 628K 615K 25.86M
Net Debt -9.4M -98.11K -85.01K -80.22K -72.78K -137K -138K -958K -369K -4.77M -368K -360K -15.17M 249M 2.6M 2.25M 2.12M 1.93M 3.61M 3.64M 25.34M 9.77M 126M 9.75M 9.53M 401M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
13
Date Price Change Volume
15/09/26 1.130 -3.42% 270,928
11/09/26 ₹1.170 +0.86% 514,801
10/09/26 ₹1.160 +3.57% 432,751
09/09/26 ₹1.120 -2.61% 431,683
08/09/26 ₹1.150 +1.77% 499,448
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!